CF Industries Holdings, Inc. Announces Agreement to Purchase Waggaman Ammonia...
Global Programming Tool Market Technological Innovations and Extensive Demand...
Are Canadas Big Five Banks Equipped to Fund Innovation?
Sports teams and venues across North Carolina lobbying for sports betting
Sources - Georgetown expected to hire Providence's Ed Cooley
Global Programming Tool Market Technological Innovations and Extensive Demand...
Are Canadas Big Five Banks Equipped to Fund Innovation?
Sports teams and venues across North Carolina lobbying for sports betting
Sources - Georgetown expected to hire Providence's Ed Cooley
Different Treatments
SciencePress Release2023-03-20 12:28:00
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (Revive or the Company) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...
EconomyPress Release2023-03-20 13:30:00
Acne Treatment Market Trends and Insights by Acne Type (Moderate, Mild, Moderate to Severe), Treatment (Medication, Therapeutic Devices), Drug Type (OTC,...
SciencePress Release2023-03-20 12:00:00
- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the...
Business / FinanceBy Business Wire2023-03-20 18:00:00
Fotona US, the leader in the design and manufacture of high technology laser systems for aesthetics and dentistry since 1964, has noted a significant demand...
TechnologyPress Release2023-03-20 10:35:00
Third positive registrational trial met its primary endpoint, with KarXT demonstrating an 8.4-point reduction in PANSS total score compared to placebo at...
HealthPress Release2023-03-20 11:08:18
Plasma Therapy Market Forecast SEATTLE, WASHINGTON, UNITED STATES, March 20, 2023 / EINPresswire.com / -- Edition: 2023
HealthPress Release2023-03-20 11:00:00
Wildberrymd Wildberry MD offers personalized treatment plans to fight hypothyroidism. We focus on optimizing the function of the thyroid gland with our...
HealthBy Vandana Singh2023-03-20 14:21:15
Takeda Pharmaceutical Co Ltd TAK announced results from a Phase 2b clinical trial of TAK-279 (NDI-034858) in patients with moderate-to-severe plaque...
PoliticsBy Health Day2023-03-20 11:47:00
By Dennis Thompson HealthDay Reporter MONDAY, March 20, 2023 (HealthDay News) -- Patients could soon have access to a new injectable drug to treat atopic...
HealthPress Release2023-03-20 12:40:00
Dr. Raphael Kellman Gives Hope to Patients; Emphasizes Value of Innovative Therapies During Autoimmune Awareness Month NEW YORK, March 20, 2023 /PRNewswire/...
HealthPress Release2023-03-20 10:00:00
Company anticipates that the c ombination of pan-TKI dovitinib and PARP inhibitor stenoparib may generate synergistic anti-cancer activity Program initiation...
Business / FinanceBy Pr Newswire2023-03-20 14:03:00
After traveling the world interviewing medical professionals, alternativehealth experts, commentators, whistleblowers, and physiciansto document the many...
SciencePress Release2023-03-20 12:00:00
Panel discussion to be held on Saturday, March 25 at 12:00pm ET / 11:00am CT / 9:00am PT. SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc....
HealthPress Release2023-03-20 01:00:00
SHANGHAI, March 19, 2023 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China, announced today that the Company has...
Business / FinancePress Release2023-03-20 10:19:32
Liver Disease market The growth of the liver disease treatment market is attributed to increase in prevalence of liver diseases, rise in drug discovery and...
PoliticsBy Health Day2023-03-20 11:34:00
By Ernie Mundell HealthDay Reporter Bile duct cancers: Funding, research needed to fight this silent killer. As too many American families have discovered,...
HealthPress Release2023-03-20 08:30:00
STEVENAGE, England, March 20, 2023 /PRNewswire/ -- New data* presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in...
Business / FinanceBy Business Wire2023-03-20 11:06:00
Cure Rare Disease (CRD) - a nonprofit biotechnology company focused on developing treatments for ultra-rare diseases - announces the appointment of leading...
HealthPress Release2023-03-20 12:00:00
CAMBRIDGE, Mass., March 20, 2023 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical-stage biotechnology company, today announced the title of an...
HealthPress Release2023-03-20 11:00:00
SAN DIEGO, March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery...